We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eli Lilly’s, Regeneron’s Monoclonal Antibodies May Need Tweaking for COVID-19 Variants
Eli Lilly’s, Regeneron’s Monoclonal Antibodies May Need Tweaking for COVID-19 Variants
A new study has found that Eli Lilly and Regeneron may need to adjust their monoclonal antibody treatments to effectively fight fast-spreading COVID-19 variants, especially the South African mutation, which along with a UK variant has raised concerns among scientists that SARS-CoV-2 may mutate to resist vaccines and treatments.